Literature DB >> 15537971

Spectrum of thymic uptake at 18F-FDG PET.

Brett Ferdinand1, Pramod Gupta, Elissa L Kramer.   

Abstract

Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has emerged as a strong diagnostic tool for the diagnosis and staging of neoplasms. Uptake in the thymus at (18)F-FDG PET complicates the assessment of mediastinal involvement by tumor in children and young adults. Increased thymic (18)F-FDG uptake may represent normal physiologic uptake but may also indicate the presence of thymic hyperplasia, lymphomatous infiltration, primary thymic neoplasm, or metastatic disease. Familiarity with the patterns of (18)F-FDG uptake that characterize these pathologic conditions is crucial to the interpretation of PET findings in the thymus. In addition, awareness of the subsets of patients in whom physiologic uptake may be seen and of the normal morphologic features and (18)F-FDG PET appearance of the thymus, along with a general sense of the upper limits of metabolic activity for physiologic thymic uptake, will aid in differentiating between physiologic thymic uptake and mediastinal disease. In equivocal cases, correlation with morphologic data from computed tomography or magnetic resonance imaging will likely continue to play a key role in diagnosis and will aid in differentiating benign thymic uptake from malignancy. (c) RSNA, 2004.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537971     DOI: 10.1148/rg.246045701

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  19 in total

1.  PET: other thoracic malignancies.

Authors:  Leslie E Quint
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

2.  (18)F-FDG PET for the evaluation of thymic epithelial tumors: Correlation with the World Health Organization classification in addition to dual-time-point imaging.

Authors:  Atsuo Inoue; Noriyuki Tomiyama; Mitsuaki Tatsumi; Naoki Ikeda; Meinoshin Okumura; Hiroyuki Shiono; Masayoshi Inoue; Ichiro Higuchi; Katsuyuki Aozasa; Takeshi Johkoh; Hironobu Nakamura; Jun Hatazawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-14       Impact factor: 9.236

3.  Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma.

Authors:  Ingeborg Goethals; Pieter Hoste; Ciel De Vriendt; Peter Smeets; Joris Verlooy; Hamphrey Ham
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-10       Impact factor: 9.236

4.  Evaluation of anterior mediastinal solid tumors by CT perfusion: a preliminary study.

Authors:  Selim Bakan; Sedat Giray Kandemirli; Atilla Süleyman Dikici; Ezel Erşen; Onur Yıldırım; Cesur Samancı; Şebnem Batur; Deniz Çebi Olgun; Fatih Kantarcı; Canan Akman
Journal:  Diagn Interv Radiol       Date:  2017 Jan-Feb       Impact factor: 2.630

5.  Comparison of CT and PET/CT for biopsy guidance in oncological patients.

Authors:  Juliano J Cerci; Elena Tabacchi; Mateos Bogoni; Dominique Delbeke; Carlos Cunha Pereira; Rodrigo J Cerci; Cassiano Krauzer; Danielle Giacometti Sakamoto; Stefano Fanti; João Vicente Vitola
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-31       Impact factor: 9.236

6.  The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma.

Authors:  Bala Basak Oven Ustaalioglu; Mesut Seker; Ahmet Bilici; Nesrin Canpolat; Emre Yıldirim; Umut Kefeli; Recep Ustaalioglu; Burçak Erkol Yilmaz; Taflan Salepci; Nagehan Ozdemir; Mahmut Gumus
Journal:  Med Oncol       Date:  2010-02-13       Impact factor: 3.064

7.  Imaging characteristics of pathologically proven thymic hyperplasia: identifying features that can differentiate true from lymphoid hyperplasia.

Authors:  Tetsuro Araki; Lynette M Sholl; Victor H Gerbaudo; Hiroto Hatabu; Mizuki Nishino
Journal:  AJR Am J Roentgenol       Date:  2014-03       Impact factor: 3.959

Review 8.  Human T cell reconstitution in DiGeorge syndrome and HIV-1 infection.

Authors:  Lori L Hudson; M Louise Markert; Blythe H Devlin; Barton F Haynes; Gregory D Sempowski
Journal:  Semin Immunol       Date:  2007-11-26       Impact factor: 11.130

9.  (18)Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography total glycolytic volume in thymic epithelial neoplasms evaluation: a reproducible image biomarker.

Authors:  Luca Bertolaccini; Andrea Viti; Eleonora Lanzi; Mirella Fortunato; Stephane Chauvie; Andrea Bianchi; Alberto Terzi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-01-30

10.  Intrapericardial primary thymic carcinoma in a 73-year-old man.

Authors:  Ana Maria Calderon; Juan Andres Merchan; Juan Carlos Rozo; Cesar Ivan Guerrero; Bernardo Treistman; Laura E Sulak; Benjamin Y C Cheong; German Rodríguez; Andrés Mesa
Journal:  Tex Heart Inst J       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.